During the past nine months a study has been made by members of the medical service at the Johns Hopkins Hospital concerning some of the possible therapeutic uses of aureomycin. Fortyeight patients with a variety of infectious processes were selected for treatment. In many cases the patients had been treated unsuccessfully with one or more chemotherapeutic agents before aureomycin was given but in each instance an effort was made to curtail other drugs during the period that aureomycin was used. Whenever possible the infectious agent was recovered before treatment with aureomycin was started, and other cultures were made during and following this therapy. The sensitivity to aureomycin of the bacteria recovered was tested in vitro in each instance.
Certain studies were made to evaluate the possible toxicity of the drug. The patients were examined daily for evidence of rashes or untoward symptoms. The blood and urine were examined before, during, and after treatment. The liver function of 37 cases was tested before and after treatment, by the thymol turbidity, cephalin flocculation, and BSP excretion tests and serial electrocardiograms were obtained from 39 cases. No patient developed drug fever or dermatitis, and no signs of toxicity to the bone marrow, kidneys, liver, or myocardium were noted. a buffer like Alugel but its effectiveness might be decreased by this procedure since it is known to deteriorate in alkaline environments. Many patients developed tolerance to aureomycin as treatment progressed. In only five cases was therapy stopped because of uncontrollable vomiting. It is of interest that four of these five were ambulant patients with sinusitis.
The patients have been divided into separate groups according to the diagnosis. The therapeutic results in each group will be considered separately.
Fifteen cases of urinary tract infection were treated. Six had chronic pyelonephritis, four had acute cystitis, three had post-operative infection with associated bacteremia, one had hydronephrosis, and one had a horse-shoe kidney. In 11 cases the infecting bacterium was E. coli, in two cases enterococcus, and in one, Pseudomonas aerugenosa. Each of the infecting strains of E. coli was inhibited in vitro by aureomycin in concentrations between 0.7 and 15 ttg./cc. of medium. The strain of pseudomonas was resistant to 50 ptg./cc. Fourteen of the 15 cases had not responded to other types of chemotherapy. The patients each received a total dosage of 4 to 32 gm. with an average of 13.2 gm. The results obtained were uniformly satisfactory except in the case of infection due to pseudomonas. All symptoms subsided within one to four days (average three and two-tenths days Three patients with lung abscess were treated. Two had chronic infections for six and nine months, respectively. The third was acutely infected. The abscess in one patient was secondary to a pulmonary adenocarcinoma. From this case a pure culture of E. coli sensitive to 0.75 /Ag./cc. of aureomycin was obtained from the pus. No improvement had been noted following treatment with penicillin and sulfadiazine. After treatment with aureomycin, 4 gm. daily for 20 days, subjective improvement was noticeable and the temperature returned to normal. Subsequently, however, both fever and symptoms recurred and surgical drainage was necessary. It is of interest that the pus then contained no E. coli but instead a pure culture of proteus.
The second chronic case with a mixed infection resistant to penicillin and streptomycin was markedly improved after receiving aureomycin 4 gm. daily for six weeks. Fever and sputum disappeared and roentgenographic examination revealed a normal lung. The third patient had multiple acute abscesses due to staphylococcus and improved dramatically when treated with aureomycin although penicillin had seemed ineffective. Six patients with sinusitis were treated with satisfactory results.
An additional group of nine patients with different types of infections was treated with good results. These included two cases of lymphopathia venereum, and one case each of Rocky Mountain Spotted Fever, rat bite fever, tonsillitis due to Streptococcus pyogenes, meningitis due to E. coli, meningitis due to pneumococcus Type XIX, rodent ulcer, lobar pneumonia, and chronic brucellosis. One case of chronic ulcerative colitis showed marked symptomatic improvement on treatment.
Unsatisfactory results were observed in five additional patients comprising one case each of thyroiditis, pemphigus, sarcoid, osteomyelitis, and typhoid fever.
Four patients with bacterial endocarditis were treated. In two the infections, due to Streptococcus fecalis, developed following the Blalock-Taussig operation. The other two patients developed spontaneous infections due to microaerophilic streptococci. The courses of these four patients are summarized in Figures 1-4 . In the case of K. S. (Figure 1) 
